Rich Deal for Millennium Stirs Biotech Stocks

Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Takeda Pharmaceutical Co.’s (4502.TO) $8.8 billion purchase of Millennium Pharmaceuticals Inc. (MLNM) is raising hopes - and stock prices - that more …

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.